BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7691070)

  • 1. Effect of retroviral integration on control of expression of a tumor marker in HeLa cells.
    Gross MM; Janiaud P; Stanbridge EJ
    Mol Carcinog; 1993; 8(2):89-95. PubMed ID: 7691070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation.
    Latham KM; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1263-7. PubMed ID: 2304898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the oncogenic potential of a tumor-associated antigen, intestinal alkaline phosphatase, in HeLa x fibroblast cell hybrids.
    Latham KM; Stanbridge EJ
    Cancer Res; 1992 Feb; 52(3):616-22. PubMed ID: 1732049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.
    Mendonca MS; Fasching CL; Srivatsan ES; Stanbridge EJ; Redpath JL
    Radiat Res; 1995 Jul; 143(1):34-44. PubMed ID: 7597142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of intestinal alkaline phosphatase expression and the tumorigenic potential of gamma-irradiated HeLa x fibroblast cell hybrids.
    Mendonca MS; Antoniono RJ; Latham KM; Stanbridge EJ; Redpath JL
    Cancer Res; 1991 Aug; 51(16):4455-62. PubMed ID: 1868467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the oncogenic potential of H19 gene in HeLa x normal human fibroblast hybrid cells.
    Tsujimoto H; Nishizuka S; Redpath LJ; Stanbridge EJ
    Int J Oncol; 2001 Jul; 19(1):89-95. PubMed ID: 11408927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells.
    Bosch FX; Schwarz E; Boukamp P; Fusenig NE; Bartsch D; zur Hausen H
    J Virol; 1990 Oct; 64(10):4743-54. PubMed ID: 2168962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.
    Lichy JH; Modi WS; Seuanez HN; Howley PM
    Cell Growth Differ; 1992 Aug; 3(8):541-8. PubMed ID: 1390339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional features of a cell surface phosphoglycoprotein associated with tumorigenic phenotype in human fibroblast x HeLa cell hybrids.
    Sutherland DR; Bicknell DC; Downward J; Parker P; Waterfield MD; Baker MA; Greaves MF; Stanbridge EJ
    J Biol Chem; 1986 Feb; 261(5):2418-24. PubMed ID: 3080434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression in tumorigenic and nontumorigenic HeLa x normal human fibroblast hybrid cells.
    Tsujimoto H; Nishizuka S; Redpath JL; Stanbridge EJ
    Mol Carcinog; 1999 Dec; 26(4):298-304. PubMed ID: 10569806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of myc gene amplification in human somatic cell hybrids.
    Iman DS; Shay JW
    Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of somatic cell hybrids derived from normal human prostatic epithelial cells fused with HeLa cells.
    Peehl DM; Wong ST; McNeal JE; Stamey TA
    Prostate; 1990; 17(2):123-36. PubMed ID: 1697966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of caveolin-1 expression in tumorigenic human cell hybrids.
    Suzuki T; Suzuki Y; Hanada K; Hashimoto A; Redpath JL; Stanbridge EJ; Nishijima M; Kitagawa T
    J Biochem; 1998 Aug; 124(2):383-8. PubMed ID: 9685730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumorigenicity in somatic cell hybrids. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid x malignant cells.
    Kaelbling M; Klinger HP
    Cytogenet Cell Genet; 1986; 41(2):65-70. PubMed ID: 3956263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
    Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of anchorage independence form tumorigenicity in human cell hybrids.
    Stanbridge EJ; Wilkinson J
    Int J Cancer; 1980 Jul; 26(1):1-8. PubMed ID: 7239708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
    Benedict WF; Weissman BE; Mark C; Stanbridge EJ
    Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexity of control of tumorigenic expression in intraspecies hybrids of human SV40-transformed fibroblasts and normal human fibroblast cell lines.
    Weissman BE; Stanbridge EJ
    Cytogenet Cell Genet; 1983; 35(4):263-8. PubMed ID: 6311488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
    Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
    Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of suppressor loci on chromosomes 11 and 14 may be required for radiation-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.
    Mendonca MS; Howard K; Fasching CL; Farrington DL; Desmond LA; Stanbridge EJ; Redpath JL
    Radiat Res; 1998 Mar; 149(3):246-55. PubMed ID: 9496887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.